Bharat Biotech’s Covaxin effective against Coronavirus strains found in India and UK

Indigenously developed Bharat Biotech’s COVID-19 vaccine – COVAXIN, has been found effective against Coronavirus strains found in India and the UK. A study published in medical journal Clinical Infectious Diseases said that Covaxin has been found to successfully neutralise all key emerging variants tested including- the double mutant strain B.1.617 and B.1.1.7. The study was conducted by National Institute of Virology and Indian Council of Medical Research (ICMR). COVAXIN is one of the three COVID-19 vaccines that are currently available in India.

Days ago, Covaxin became the first COVID-19 vaccine to receive a nod by the Drugs Controller General of India (DCGI) for conducting Phase 2-3 trials on 2-18-year-olds in India. The trials are expected to be completed in the next 2-3 months.


The Dispatch is present across a number of social media platforms. Subscribe to our YouTube channel for exciting videos; join us on Facebook, Intagram and Twitter for quick updates and discussions. We are also available on the Telegram. Follow us on Pinterest for thousands of pictures and graphics. We care to respond to text messages on WhatsApp at 8082480136 [No calls accepted]. To contribute an article or pitch a story idea, write to us at [email protected] |Click to know more about The Dispatch, our standards and policies